Quantitative proteomic analysis by iTRAQ<sup>® </sup>for the identification of candidate biomarkers in ovarian cancer serum
<p>Abstract</p> <p>Background</p> <p>Ovarian cancer is the most lethal gynecologic malignancy, with the majority of cases diagnosed at an advanced stage when treatments are less successful. Novel serum protein markers are needed to detect ovarian cancer in its earliest...
Main Authors: | Higgins LeeAnn, Anderson Lorraine B, Andersen John D, Boylan Kristin LM, Skubitz Amy PN |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | Proteome Science |
Online Access: | http://www.proteomesci.com/content/8/1/31 |
Similar Items
-
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
by: Agata Swiatly, et al.
Published: (2018-07-01) -
An informatic pipeline for the data capture and submission of quantitative proteomic data using iTRAQ<smcaps><sup>TM</sup></smcaps>
by: Hart Sarah R, et al.
Published: (2007-02-01) -
Identification of Urinary Biomarkers for Exercise-Induced Immunosuppression by iTRAQ Proteomics
by: Guoqin Xu, et al.
Published: (2020-01-01) -
i-Tracker: For quantitative proteomics using iTRAQ™
by: Lilley Kathryn S, et al.
Published: (2005-10-01) -
Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis
by: Shan N, et al.
Published: (2016-04-01)